Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 9.08 M | $7.00 B | 0.30% | 8.82% |
| BLACKROCK, INC. | 02/12/2026 | 8.74 M | $6,747.12 B | -1.09% | 8.49% |
| STATE STREET CORP | 02/13/2026 | 4.66 M | $3.60 B | -0.65% | 4.53% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.94 M | $3.04 B | -3.25% | 3.77% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.56 M | $1.98 B | 4.36% | 2.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.52 M | $1.94 B | -0.65% | 2.45% |
| NUVEEN, LLC | 02/12/2026 | 2.01 M | $1,551.86 B | 71.07% | 1.95% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 1.93 M | $1.49 B | -2.28% | 1.88% |
| CAPITAL WORLD INVESTORS | 02/11/2026 | 1.40 M | $1.08 B | -30.04% | 1.36% |
| MORGAN STANLEY | 02/13/2026 | 1.39 M | $1,072.38 B | -4.25% | 1.35% |
| NORGES BANK | 02/10/2026 | 1.31 M | $1.01 B | 100.00% | 1.27% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.16 M | $893.38 B | 0.30% | 1.12% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.10 M | $846.82 M | 15.14% | 1.07% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 995.71 K | $768.52 M | 38.03% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 778.00 K | $600.52 M | 2.97% | 0.74% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 764.24 K | $589.90 M | 13.79% | 0.74% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 763.93 K | $589.65 M | 9.65% | 0.73% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 745.23 K | $575.22 M | 0.14% | 0.72% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 743.03 K | $573.52 M | -3.55% | 0.72% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 639.60 K | $493.69 M | 2.47% | 0.61% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 604.54 K | $466.63 M | -34.73% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 610.50 K | $471.23 M | -7.26% | 0.58% |
| JANE STREET GROUP, LLC | 02/12/2026 | 516.20 K | $398.44 B | 15.82% | 0.50% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 499.54 K | $385.59 M | 0.09% | 0.49% |
| MARSHALL WACE, LLP | 02/13/2026 | 478.55 K | $369.38 M | 23.69% | 0.47% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 445.80 K | $344.05 M | -23.73% | 0.43% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 440.84 K | $340.27 M | -7.71% | 0.43% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 422.13 K | $325.83 M | 1.54% | 0.40% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 421.23 K | $325.26 M | 10.55% | 0.40% |
| CENTIVA CAPITAL, LP | 02/13/2026 | 407.10 K | $314.23 M | 1.78% | 0.39% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 397.55 K | $306.86 M | 6.22% | 0.39% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 367.87 K | $284.72 M | 13.76% | 0.36% |
| NATIONAL PENSION SERVICE | 02/10/2026 | 360.99 K | $278.64 M | 29.79% | 0.35% |
| ROYAL BANK OF CANADA | 02/17/2026 | 345.22 K | $266.47 M | -7.47% | 0.33% |
| BARCLAYS PLC | 02/13/2026 | 311.17 K | $240.18 B | -4.53% | 0.30% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 294.05 K | $226.76 M | 130.56% | 0.29% |
| SWISS NATIONAL BANK | 02/12/2026 | 285.46 K | $220.34 M | -6.71% | 0.28% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 285.03 K | $220.01 M | -7.24% | 0.28% |
| EPOCH INVESTMENT PARTNERS, INC. | 02/13/2026 | 281.34 K | $217.15 M | 8.56% | 0.27% |
| UBS GROUP AG | 01/29/2026 | 271.16 K | $209.30 B | -20.13% | 0.26% |
| CITADEL ADVISORS LLC | 02/17/2026 | 274.00 K | $211.49 M | 66.36% | 0.26% |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 01/23/2026 | 261.85 K | $202.11 M | 116.61% | 0.25% |
| CITADEL ADVISORS LLC | 02/17/2026 | 265.30 K | $204.78 M | 27.00% | 0.25% |
| FEDERATED HERMES, INC. | 02/12/2026 | 246.62 K | $190.36 M | 4.41% | 0.24% |
| CITIGROUP INC | 02/13/2026 | 245.34 K | $189.37 M | 77.53% | 0.23% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 233.23 K | $180.02 M | -51.19% | 0.23% |
| SWEDBANK AB | 02/09/2026 | 227.78 K | $175.82 M | 9.84% | 0.22% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 02/03/2026 | 224.86 K | $174.56 M | 4.02% | 0.22% |
| DEKABANK DEUTSCHE GIROZENTRALE | 01/28/2026 | 211.21 K | $206.79 M | 0.00% | 0.21% |
| MCDONALD CAPITAL INVESTORS INC/CA | 01/30/2026 | 208.24 K | $160.73 M | -2.39% | 0.20% |
Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 1661 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 9.08 M
BlackRock, Inc.: 8.74 M
STATE STREET CORP: 4.66 M
JPMORGAN CHASE & CO: 3.94 M
FRANKLIN RESOURCES INC: 2.56 M
GEODE CAPITAL MANAGEMENT, LLC: 2.52 M
47.65% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 91.12 M shares in the last 24 months. This purchase volume represents approximately $72.18 B in transactions.